Spineart has launched a secured anterior cervical cage, the Scarlet AC-Ti, in the U.S.
Scarlet earned FDA clearance in May 2024, and has been evaluated in several clinical trials, according to a June 5 news release.
Zakhria Belasher, MD, a surgeon at Insight Surgical Hospital in Warren, Mich., has implanted more than 50 Scarlet AC-Ti devices so far.
The Scarlet AC-Ti builds on a decade of experience with the Scarlet system and utilizes its Ti-Life technology that provides a porous structure that closely mimics the trabecular bone structure.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
